Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review

被引:10
|
作者
Visco, Diego Bulcao [1 ]
Manhaes-de-Castro, Raul [2 ]
Chaves, Wenicios Ferreira [1 ]
Lacerda, Diego Cabral [1 ]
Pereira, Sabrina da Conceicao [3 ]
Ferraz-Pereira, Kelli Nogueira [4 ]
Toscano, Ana Elisa [5 ]
机构
[1] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Postgrad Program Phys Therapy, Recife, PE, Brazil
[4] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, PE, Brazil
[5] Univ Fed Pernambuco, CAV, Dept Nursing, Rua Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil
关键词
Serotonin uptake inhibitors; Serotonin; Skeletal muscle; Systematic review; CONGENITAL MYASTHENIC SYNDROME; CUTANEOUS SILENT PERIOD; FLUOXETINE TREATMENT; MYOTONIC-DYSTROPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; NEONATAL TREATMENT; DIABETES-MELLITUS; RAT; ANTIDEPRESSANTS;
D O I
10.1016/j.phrs.2018.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective Serotonin Reuptake Inhibitors (SSRIs) may have side effects, such as stiffness, tremors and altered tonic activity, as well as an increased risk of developing insulin resistance and diabetes mellitus. However, little is known about the structural, functional and metabolic changes of skeletal muscle after administration of SSRIs. The aim of this systematic review was to explore and discuss the effects of SSRIs on skeletal muscle properties described in human and rodent studies. A systematic search of PUBMED, SCOPUS, and WEB OF SCIENCE was performed. The inclusion criteria were intervention studies in humans and rodents that analysed the effects of SSRIs on skeletal muscle properties. The research found a total of six human studies, including two randomized controlled trials, one non-randomized controlled trial, one uncontrolled before-after study and two case reports, and six preclinical studies in rodents. Overall, the studies in humans and rodents showed altered electrical activity in skeletal muscle function, assessed through electromyography (EMG) and needle EMG in response to chronic treatment or local injection with SSRIs. In addition, rodent studies reported that SSRIs may exert effects on muscle weight, the number of myocytes and the cross-sectional area of skeletal muscle fibre. The results showed effects in energy metabolism associated with chronic SSRI use, reporting altered levels of glycogen synthase activity, acetyl-CoA carboxylase phosphorylation, citrate synthase activity, and protein kinase B Ser phosphorylation. Moreover, changes in insulin signalling and glucose uptake were documented. In this context, we concluded based on human and rodent studies that SSRIs affect electrical muscle activity, structural properties and energy metabolism in skeletal muscle tissue. However, these changes varied according to pre-existing metabolic and functional conditions in the rodents and humans.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 50 条
  • [41] Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    Zhou, C.
    Fang, L.
    Chen, Y.
    Zhong, J.
    Wang, H.
    Xie, P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (06) : 1243 - 1251
  • [42] Review of the Evidence for Treatment of Children with Autism with Selective Serotonin Reuptake Inhibitors
    West, Lis
    Brunssen, Susan H.
    Waldrop, Julee
    JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING, 2009, 14 (03) : 183 - 191
  • [43] Serotonin Syndrome in Children and Adolescents Exposed to Selective Serotonin Reuptake Inhibitors - A Review of Literature
    Xuev, Siqi
    Ickowicz, Abel
    JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 30 (03) : 156 - 164
  • [44] Effects of tricyclic antidepressants, selective serotonin reuptake inhibitors, and selective serotonin-norepinephrine reuptake inhibitors on the ocular surface
    Ismayilov, Ayna Sariyeva
    Celikel, Guler
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2023, 86 (05)
  • [45] Selective serotonin reuptake inhibitors and atypical antidepressants: A review and update for psychologists
    RivasVazquez, RA
    Blais, MA
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 1997, 28 (06) : 526 - 536
  • [46] Effects of selective serotonin reuptake inhibitors on platelet functions: a literature review
    Mokhtarian, Antoine
    Siguret, Virginie
    Jourdi, Georges
    CURRENT OPINION IN HEMATOLOGY, 2025, 32 (01) : 22 - 33
  • [47] Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
    Vaswani, M
    Linda, FK
    Ramesh, S
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (01) : 85 - 102
  • [48] Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk A Review of the Literature
    Roose, Steven P.
    Rutherford, Bret R.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) : 704 - 709
  • [49] Bursts and the Efficacy of Selective Serotonin Reuptake Inhibitors
    Best, J.
    Nijhout, H. F.
    Reed, M.
    PHARMACOPSYCHIATRY, 2011, 44 : S76 - S83
  • [50] Selective serotonin reuptake inhibitors for premenstrual syndrome
    Brown, Julie
    O'Brien, Patrick Michael Shaughn
    Marjoribanks, Jane
    Wyatt, Katrina
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):